All Things Financial Management

The Potential - and Pitfalls - of Biosimilars - Eric Snyder


Listen Later

With a $30B global forecast, biosimilars of market-leading therapeutics are a reality. We discuss their potential and how reimbursement is an obstacle to broad adoption.
...more
View all episodesView all episodes
Download on the App Store

All Things Financial ManagementBy Guidehouse